Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 7
1996 8
1997 15
1998 11
1999 25
2000 41
2001 46
2002 69
2003 95
2004 122
2005 160
2006 157
2007 150
2008 138
2009 136
2010 129
2011 142
2012 129
2013 143
2014 105
2015 78
2016 80
2017 70
2018 70
2019 65
2020 65
2021 58
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

2,095 results
Results by year
Filters applied: . Clear all
Page 1
Ziprasidone.
[No authors listed] [No authors listed] 2021 Aug 16. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Aug 16. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000199 Free Books & Documents. Review.
Because there is little published experience with ziprasidone during breastfeeding, other antipsychotic agents may be preferred, especially while nursing a newborn or preterm infant. A safety scoring system finds ziprasidone possible to use cautiously during breastf …
Because there is little published experience with ziprasidone during breastfeeding, other antipsychotic agents may be preferred, espe …
Ziprasidone.
[No authors listed] [No authors listed] 2020 Jul 1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Jul 1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643974 Free Books & Documents. Review.
Ziprasidone is an atypical antipsychotic used in the treatment of schizophrenia and bipolar disorder. Use of ziprasidone has not been consistently associated with serum enzyme elevations and has yet to be linked to instances of clinically apparent acute liver injury
Ziprasidone is an atypical antipsychotic used in the treatment of schizophrenia and bipolar disorder. Use of ziprasidone has n
Ziprasidone.
Bouchette D, Fariba KA, Marwaha R. Bouchette D, et al. 2021 Dec 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. 2021 Dec 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 28846230 Free Books & Documents. Review.
Ziprasidone is an atypical antipsychotic drug used to treat schizophrenia, bipolar mania, and acute agitation in schizophrenic patients. ...This activity outlines the indications, mechanism of action, administration methods, significant adverse effects, contraindications,
Ziprasidone is an atypical antipsychotic drug used to treat schizophrenia, bipolar mania, and acute agitation in schizophrenic patien
Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department.
Martel ML, Driver BE, Miner JR, Biros MH, Cole JB. Martel ML, et al. Acad Emerg Med. 2021 Apr;28(4):421-434. doi: 10.1111/acem.14124. Epub 2020 Oct 5. Acad Emerg Med. 2021. PMID: 32888340 Clinical Trial.
Patients were randomized to receive 5 mg of droperidol, 10 mg of ziprasidone, 20 mg of ziprasidone, or 2 mg of lorazepam intramuscularly. ...Numerically, respiratory depression was lower with droperidol (3/25 [12%]) compared to 10 mg of ziprasidone (10/28 [36 …
Patients were randomized to receive 5 mg of droperidol, 10 mg of ziprasidone, 20 mg of ziprasidone, or 2 mg of lorazepam intra …
Ziprasidone in the treatment of affective disorders: a review.
Rosa AR, Franco C, Torrent C, Comes M, Cruz N, Horga G, Benabarre A, Vieta E. Rosa AR, et al. CNS Neurosci Ther. 2008 Winter;14(4):278-86. doi: 10.1111/j.1755-5949.2008.00056.x. CNS Neurosci Ther. 2008. PMID: 19040553 Free PMC article. Review.
In two of them, ziprasidone was associated to significant improvement in the primary measures assessed. ...Particularly, subjects treated with ziprasidone were less likely to switch to depression. Despite the well-studied efficacy of ziprasidone in the first …
In two of them, ziprasidone was associated to significant improvement in the primary measures assessed. ...Particularly, subjects tre …
Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.
Greenberg WM, Citrome L. Greenberg WM, et al. CNS Drug Rev. 2007 Summer;13(2):137-77. doi: 10.1111/j.1527-3458.2007.00008.x. CNS Drug Rev. 2007. PMID: 17627670 Free PMC article. Review.
Ziprasidone is a newer "atypical" or "second-generation" antipsychotic. ...Ziprasidone intramuscular (ziprasidone mesylate) is FDA-approved for acute agitation in patients with schizophrenia. ...
Ziprasidone is a newer "atypical" or "second-generation" antipsychotic. ...Ziprasidone intramuscular (ziprasidone mesyl
Ziprasidone.
Davis R, Markham A. Davis R, et al. CNS Drugs. 1997 Aug;8(2):153-9. doi: 10.2165/00023210-199708020-00006. CNS Drugs. 1997. PMID: 23338220
The effects of ziprasidone in receptor binding studies reflected its in vitro pharmacology, with more potent effects against 5-HT(2) receptor- than against D(2) receptor-mediated behaviour. Because ziprasidone inhibits serotonin (5-hydroxytryptamine; 5-HT) and norad …
The effects of ziprasidone in receptor binding studies reflected its in vitro pharmacology, with more potent effects against 5-HT(2) …
Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar disorder in adults.
Citrome L. Citrome L. Expert Rev Neurother. 2010 Jul;10(7):1031-7. doi: 10.1586/ern.10.66. Expert Rev Neurother. 2010. PMID: 20586686 Review.
A total of 238 subjects were analyzed for efficacy in the double-blind period (ziprasidone 127, placebo 111). Ziprasidone was superior to placebo in increasing the time to recurrence of a mood episode (p = 0.0104) during the 6 months of double-blind treatment. ...Th …
A total of 238 subjects were analyzed for efficacy in the double-blind period (ziprasidone 127, placebo 111). Ziprasidone was …
Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review.
Sacchetti E, Galluzzo A, Valsecchi P. Sacchetti E, et al. Expert Rev Clin Pharmacol. 2011 Mar;4(2):163-79. doi: 10.1586/ecp.10.139. Expert Rev Clin Pharmacol. 2011. PMID: 22115400 Review.
The same applies when ziprasidone is administered in combination with lithium or valproate for the prevention of affective relapses and recurrences. Any conclusion on the potential of ziprasidone as an antidepressant should be postponed because of insufficient evide …
The same applies when ziprasidone is administered in combination with lithium or valproate for the prevention of affective relapses a …
Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder.
Warrington L, Lombardo I, Loebel A, Ice K. Warrington L, et al. CNS Drugs. 2007;21(10):835-49. doi: 10.2165/00023210-200721100-00004. CNS Drugs. 2007. PMID: 17850172 Review.
Ziprasidone, a benzisothiazolyl piperazine-type atypical antipsychotic agent, has a unique receptor-binding profile. ...Ziprasidone-related movement disorders occurred infrequently....
Ziprasidone, a benzisothiazolyl piperazine-type atypical antipsychotic agent, has a unique receptor-binding profile. ...Ziprasidon
2,095 results